Rhinotracheitis, Calici Virus, Panleukopenia
24 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
24
Total Reports
3
Deaths Reported
1250.0%
Death Rate
Active Ingredients
Rhinotracheitis, Calici Virus, Panleukopenia
Administration Routes
UnknownSubcutaneous
Species Affected
Cat 24
Most Affected Breeds
Domestic Shorthair 16
Domestic Mediumhair 3
Cat (unknown) 1
Siamese 1
Maine Coon 1
Domestic Longhair 1
Turkish Van 1
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 9
Application site alopecia 7
Emesis (multiple) 4
Weight loss 4
Ataxia 4
Death 3
Decreased appetite 3
Application site erythema 3
Hypersalivation 3
Anorexia 3
Grooming disorder 2
Application site hot spot 2
Outcome Breakdown
Outcome Unknown
16 (66.7%)
Recovered/Normal
5 (20.8%)
Died
3 (12.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.